BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar
View ORCID ProfilePatrick Tang, Mohammad R. Hasan, View ORCID ProfileHiam Chemaitelly, View ORCID ProfileHadi M. Yassine, View ORCID ProfileFatiha M. Benslimane, Hebah A. Al Khatib, View ORCID ProfileSawsan AlMukdad, View ORCID ProfilePeter Coyle, View ORCID ProfileHoussein H. Ayoub, View ORCID ProfileZaina Al Kanaani, View ORCID ProfileEinas Al Kuwari, View ORCID ProfileAndrew Jeremijenko, View ORCID ProfileAnvar Hassan Kaleeckal, Ali Nizar Latif, View ORCID ProfileRiyazuddin Mohammad Shaik, View ORCID ProfileHanan F. Abdul Rahim, View ORCID ProfileGheyath K. Nasrallah, View ORCID ProfileMohamed Ghaith Al Kuwari, View ORCID ProfileHamad Eid Al Romaihi, View ORCID ProfileAdeel A. Butt, View ORCID ProfileMohamed H. Al-Thani, Abdullatif Al Khal, View ORCID ProfileRoberto Bertollini, View ORCID ProfileLaith J. Abu-Raddad
doi: https://doi.org/10.1101/2021.08.11.21261885
Patrick Tang
1Department of Pathology, Sidra Medicine, Doha, Qatar
Mohammad R. Hasan
1Department of Pathology, Sidra Medicine, Doha, Qatar
Hiam Chemaitelly
2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
Hadi M. Yassine
4Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
5Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Fatiha M. Benslimane
4Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
5Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Hebah A. Al Khatib
4Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
5Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Sawsan AlMukdad
2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
Peter Coyle
4Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
6Hamad Medical Corporation, Doha, Qatar
7Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom
Houssein H. Ayoub
8Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar
Zaina Al Kanaani
6Hamad Medical Corporation, Doha, Qatar
Einas Al Kuwari
6Hamad Medical Corporation, Doha, Qatar
Andrew Jeremijenko
6Hamad Medical Corporation, Doha, Qatar
Anvar Hassan Kaleeckal
6Hamad Medical Corporation, Doha, Qatar
Ali Nizar Latif
6Hamad Medical Corporation, Doha, Qatar
Riyazuddin Mohammad Shaik
6Hamad Medical Corporation, Doha, Qatar
Hanan F. Abdul Rahim
9Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar
Gheyath K. Nasrallah
4Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
5Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Mohamed Ghaith Al Kuwari
10Primary Health Care Corporation, Doha, Qatar
Hamad Eid Al Romaihi
11Ministry of Public Health, Doha, Qatar
Adeel A. Butt
6Hamad Medical Corporation, Doha, Qatar
12Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
Mohamed H. Al-Thani
11Ministry of Public Health, Doha, Qatar
Abdullatif Al Khal
6Hamad Medical Corporation, Doha, Qatar
Roberto Bertollini
11Ministry of Public Health, Doha, Qatar
Laith J. Abu-Raddad
2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
9Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar
12Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA

Data Availability
The dataset of this study is a property of the Qatar Ministry of Public Health that was provided to the researchers through a restricted-access agreement that prevents sharing the dataset with a third party or publicly. Future access to this dataset can be considered through a direct application for data access to Her Excellency the Minister of Public Health (https://www.moph.gov.qa/english/Pages/default.aspx). Aggregate data are available within the manuscript and its Supplementary information.
Posted August 11, 2021.
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar
Patrick Tang, Mohammad R. Hasan, Hiam Chemaitelly, Hadi M. Yassine, Fatiha M. Benslimane, Hebah A. Al Khatib, Sawsan AlMukdad, Peter Coyle, Houssein H. Ayoub, Zaina Al Kanaani, Einas Al Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al Kuwari, Hamad Eid Al Romaihi, Adeel A. Butt, Mohamed H. Al-Thani, Abdullatif Al Khal, Roberto Bertollini, Laith J. Abu-Raddad
medRxiv 2021.08.11.21261885; doi: https://doi.org/10.1101/2021.08.11.21261885
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar
Patrick Tang, Mohammad R. Hasan, Hiam Chemaitelly, Hadi M. Yassine, Fatiha M. Benslimane, Hebah A. Al Khatib, Sawsan AlMukdad, Peter Coyle, Houssein H. Ayoub, Zaina Al Kanaani, Einas Al Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al Kuwari, Hamad Eid Al Romaihi, Adeel A. Butt, Mohamed H. Al-Thani, Abdullatif Al Khal, Roberto Bertollini, Laith J. Abu-Raddad
medRxiv 2021.08.11.21261885; doi: https://doi.org/10.1101/2021.08.11.21261885
Subject Area
Subject Areas
- Addiction Medicine (228)
- Allergy and Immunology (506)
- Anesthesia (110)
- Cardiovascular Medicine (1244)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (10027)
- Gastroenterology (500)
- Genetic and Genomic Medicine (2462)
- Geriatric Medicine (238)
- Health Economics (479)
- Health Informatics (1645)
- Health Policy (753)
- Hematology (250)
- HIV/AIDS (535)
- Medical Education (253)
- Medical Ethics (75)
- Nephrology (268)
- Neurology (2289)
- Nursing (139)
- Nutrition (352)
- Oncology (1248)
- Ophthalmology (377)
- Orthopedics (134)
- Otolaryngology (226)
- Pain Medicine (158)
- Palliative Medicine (50)
- Pathology (325)
- Pediatrics (733)
- Primary Care Research (282)
- Public and Global Health (4840)
- Radiology and Imaging (838)
- Respiratory Medicine (651)
- Rheumatology (286)
- Sports Medicine (227)
- Surgery (268)
- Toxicology (44)
- Transplantation (125)
- Urology (99)